Abstract
Background: Syphilis is a chronic infectious disease caused by Treponema pallidum (Tp) infection, which causes local inflammation in the host. TpF1 is an oligomeric protein expressed by the Tp-infected host that can induce the host immune response. There are few studies regarding the role of TpF1 in macrophage activation and the subsequent release of cytokines.
Objective: The objective of this study is to elucidate the effects of TpF1 on the pathological process of Syphilis. In addition, we explored how purinergic 2X7 (P2X7R) induced NOD-like receptor family protein 3 (NLRP3) -dependent release of interleukin-1β (IL-1β) and the underlying mechanisms.
Methods: We explored the influence of TpF1 on cytokine release by macrophages using qRT-PCR and ELISA. The specific phenotype of activated macrophages was determined by flow cytometry.
Results: TpF1 was able to activate macrophages and induce the M1 macrophage phenotype. Moreover, TpF1 activated the NLRP3 inflammasome in macrophages, which was mediated by P2X7R.
Conclusion: The Tp-induced protein TpF1 is able to induce macrophage activation and P2X7R-induced NLRP3-dependent release of IL-1β. Our findings provide a theoretical basis for clarifying the clinical symptoms and pathogenesis of syphilis.
Keywords: Treponema pallidum, TpF1, macrophage, NLRP3, P2X7R, IL-1β.
[http://dx.doi.org/10.1056/NEJMra1901593] [PMID: 32101666]
[http://dx.doi.org/10.1038/nrmicro.2016.141] [PMID: 27721440]
[http://dx.doi.org/10.1038/nrdp.2017.73] [PMID: 29022569]
[http://dx.doi.org/10.1016/bs.ai.2019.11.003] [PMID: 32081200]
[http://dx.doi.org/10.1111/jdv.16463] [PMID: 32294266]
[http://dx.doi.org/10.4049/jimmunol.1100615] [PMID: 21709157]
[http://dx.doi.org/10.1038/srep18785] [PMID: 26728351]
[http://dx.doi.org/10.1186/s12865-018-0265-9] [PMID: 30217146]
[http://dx.doi.org/10.1002/prot.20828] [PMID: 16345079]
[http://dx.doi.org/10.1172/JCI57173] [PMID: 22133883]
[http://dx.doi.org/10.1038/nmicrobiol.2016.245] [PMID: 27918528]
[http://dx.doi.org/10.1016/j.intimp.2018.03.040] [PMID: 29656208]
[http://dx.doi.org/10.1186/s12879-018-2993-0] [PMID: 29490620]
[http://dx.doi.org/10.1093/infdis/165.1.69] [PMID: 1727898]
[http://dx.doi.org/10.1155/2017/1436080] [PMID: 28523273]
[http://dx.doi.org/10.1128/CVI.00122-13] [PMID: 23945159]
[http://dx.doi.org/10.1016/j.smim.2018.09.001] [PMID: 30268598]
[http://dx.doi.org/10.1111/j.1600-065X.2011.01046.x] [PMID: 21884173]
[http://dx.doi.org/10.1096/fj.14-268714] [PMID: 25690658]
[http://dx.doi.org/10.1096/fj.14-267393] [PMID: 26116704]
[http://dx.doi.org/10.1016/j.intimp.2020.106344] [PMID: 32151957]
[http://dx.doi.org/10.1016/j.immuni.2018.04.032] [PMID: 29958799]